EconPapers    
Economics at your fingertips  
 

Folic acid and neural tube defect: Can't we come to closure?

W.C. Willett

American Journal of Public Health, 1992, vol. 82, issue 5, 666-668

Abstract: In a series of nonrandomized and randomized intervention trials and case- control and cohort studies, women using multivitamins or folic acid supplements during the first 6 weeks of pregnancy experienced a three- to fourfold reduction in neural tube defects among their offspring. Viewed collectively, these data provide strong evidence that an important subset of US women do not receive sufficient folic acid to minimize their risk of a defective pregnancy. Further, the amounts of folic acid contained in multivitamins (usually 200-400 μg per day) appear adequate to greatly reduce, and probably eliminate, the excess risk.

Date: 1992
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:aph:ajpbhl:1992:82:5:666-668_7

Access Statistics for this article

American Journal of Public Health is currently edited by Alfredo Morabia

More articles in American Journal of Public Health from American Public Health Association
Bibliographic data for series maintained by Christopher F Baum ().

 
Page updated 2025-03-19
Handle: RePEc:aph:ajpbhl:1992:82:5:666-668_7